Spero Therapeutics, Inc. Annual Income Tax Expense (Benefit) in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Spero Therapeutics, Inc. annual/quarterly Income Tax Expense (Benefit) history and growth rate from 2015 to 2023.
  • Spero Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2023 was $2.21M.
  • Spero Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was $2.6M.
  • Spero Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $0.000.
  • Spero Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was $0.000.
Income Tax Expense (Benefit), Annual (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $2.6M +$2.6M Jan 1, 2023 Dec 31, 2023 10-K 2024-03-13
2022 $0 $0 Jan 1, 2022 Dec 31, 2022 10-K 2024-03-13
2021 $0 $0 Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 $0 $0 Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 $0 $0 Jan 1, 2019 Dec 31, 2019 10-K 2021-03-11
2018 $0 $0 Jan 1, 2018 Dec 31, 2018 10-K 2020-03-16
2017 $0 $0 Jan 1, 2017 Dec 31, 2017 10-K 2019-03-14
2016 $0 $0 Jan 1, 2016 Dec 31, 2016 10-K 2019-03-14
2015 $0 Jan 1, 2015 Dec 31, 2015 10-K 2018-04-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.